The dChip survival analysis module for microarray data
暂无分享,去创建一个
Parantu K. Shah | Sophia Adamia | Aimin Yan | Cheng Li | Herve Avet-Loiseau | Samir B. Amin | Stéphane Minvielle | Nikhil C. Munshi | N. Munshi | Cheng Li | S. Minvielle | H. Avet-Loiseau | S. Amin | P. Shah | Sophia Adamia | Aimin Yan
[1] George A Calin,et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.
[2] Xihong Lin,et al. New Developments in Biostatistics and Bioinformatics , 2009 .
[3] Cheng Li,et al. Prognostic significance of copy-number alterations in multiple myeloma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Ivan Porro,et al. Survival Online: a web-based service for the analysis of correlations between gene expression and clinical and follow-up data , 2009, BMC Bioinformatics.
[5] Luc Girard,et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. , 2004, Cancer research.
[6] A. Vigano,et al. Survival prediction in terminal cancer patients: a systematic review of the medical literature , 2000, Palliative medicine.
[7] Bart Barlogie,et al. Genetics and Cytogenetics of Multiple Myeloma , 2004, Cancer Research.
[8] Cheng Li,et al. Analysis of Cancer Genome Alterations Using Single Nucleotide Polymorphism (SNP) Microarrays , 2009 .
[9] Yi Zhang,et al. Copy number alterations that predict metastatic capability of human breast cancer. , 2009, Cancer research.
[10] Soonmyung Paik,et al. Gene-expression-based prognostic assays for breast cancer , 2010, Nature Reviews Clinical Oncology.
[11] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] Yogendra P. Chaubey. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .
[13] Stephanie Roessler,et al. MicroRNA expression, survival, and response to interferon in liver cancer. , 2009, The New England journal of medicine.
[14] Oliver Hofmann,et al. Genome-wide analysis of cancer/testis gene expression , 2008, Proceedings of the National Academy of Sciences.
[15] Z. Szallasi,et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.
[16] A Briggs,et al. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. , 2006, Health technology assessment.
[17] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. S. Young,et al. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .
[19] Yingdong Zhao,et al. Analysis of Gene Expression Data Using BRB-Array Tools , 2007, Cancer informatics.
[20] Laurence Lodé,et al. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[22] Jan Mollenhauer,et al. Candidate genes for cross-resistance against DNA-damaging drugs. , 2002, Cancer research.